Both in Biotechnology
MeiraGTx Holdings vs Monte Rosa Therapeutics
Over the past year MGTX returned +33.7% and GLUE returned +61.0%; their daily moves had a correlation of 0.19.
MGTX +33.7% GLUE +61.0%Growth of $1, one year, split-adjusted
| Metric | MGTX | GLUE |
|---|---|---|
| Price | $11.00 | $11.93 |
| Market cap | $1.06B | $1.02B |
| Today | −1.17% | +1.62% |
| 1 month | −20.3% | −14.4% |
| 6 months | +27.0% | −27.5% |
| Year to date | +38.4% | −23.9% |
| 1 year | +33.3% | +63.2% |
| Revenue growth (YoY) | +8608.6% | −61.3% |
| Gross margin | 97.8% | 100.0% |
| Net margin | 50.0% | −483.9% |
| P/E (TTM) | 13.4× | — |
| Price / sales | 2.7× | 35.4× |
| Net cash | $21.8M | $621.1M |
| Dividend yield | — | — |
| Volatility (60d) | 45.0% | 81.1% |
| Short % of float | 6.7% | 39.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).